China Net Finance, January 9 (Reporter Shan Shengqun) On January 8, Huaxia Ophthalmology (301267SZ) announced that the company intends to use its own funds to repurchase part of the company's shares in a centralized bidding transaction, and the total amount of repurchase funds shall not be less than 1500 million yuan and not more than 2500 million yuan, repurchase ** no more than 50$93 shares.
It is understood that the repurchased shares of Huaxia Ophthalmology Institute will be used to implement employee stock ownership plans or equity incentives. Based on the total amount of repurchase funds and the upper limit of repurchase**, the company expects to repurchase about 294 shares520,000 shares - 490870,000 shares, accounting for about 035%-0.58%。
Huaxia Ophthalmology said in the announcement that as of September 30, 2023, the company's unaudited total assets were 732.2 billion yuan, and the net assets attributable to shareholders of listed companies were 55300 million yuan, total liabilities 172.8 billion yuan, the company's asset-liability ratio is 2359% and the balance of monetary funds is 230.9 billion yuan, the company's financial position is good.
Senior brokerage analysts told China.com financial reporters that share buybacks are a measure for listed companies to release good signals. For investors, share buybacks mean fewer shares circulating in the market, helping to stabilize the stock price.
In addition, from the perspective of the operation of Huaxia Ophthalmology, the company's performance has grown steadily since its listing, and the net profit attributable to the parent company has been 5 in the first three quarters of 20235.7 billion yuan, exceeding the net profit attributable to the parent company realized in 2022.
At the same time, Huaxia Ophthalmology is still accelerating its expansion. Financial data show that from the third quarter of 2022 to the third quarter of 2023, the total assets of Huaxia Ophthalmology increased from 369.9 billion yuan doubled to 732.2 billion yuan.
At an investor relations event in October 2023, Huaxia Ophthalmology said that it had built and acquired more than 20 eye hospitals in 2023, and it is expected to complete the layout of 24 provincial capitals in 2024, followed by prefecture-level cities. In the future, the company will promote the layout plan of 20-30 ophthalmology hospitals every year.